The United Kingdom Children's Cancer Study Group--the first 20 years of growth and development. (Q41616692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

The United Kingdom Children's Cancer Study Group--the first 20 years of growth and development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

M G Mott

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J R Mann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

1448-1452

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

Centralisation of treatment and survival rates for cancer

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Trends in survival for childhood cancer in Britain diagnosed 1971-85

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Childhood cancer and ethnic group in Britain: a United Kingdom children's Cancer Study Group (UKCCSG) study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Population based survival rates for childhood cancer in Britain, 1980-91.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Childhood cancer in Britain: the National Registry of Childhood Tumours and incidence rates 1978-1987.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Treatment of clinical stage I Hodgkin's disease by local radiation therapy alone. A United Kingdom Childrens Cancer Study Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Adjuvant low dose radiation in childhood non-Hodgkin's lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukaemia with the UKCCSG regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86)--how much treatment is needed? United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Causes of death in children diagnosed with non-Hodgkin's lymphoma between 1974 and 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Childhood T-cell lymphoblastic lymphoma--does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears. United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Overtreatment of children with Wilms' tumour outside paediatric oncology centres

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

How curable is relapsed Wilms' tumour? The United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Response rates in relapsed wilms' tumor. A need for new effective agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

'JEB' – a carboplatin based regimen for malignant germ cell tumours in children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Incidence of second primary tumours among childhood cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Late deaths and survival after childhood cancer: implications for cure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

Gonadal function following chemotherapy for childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900250-5

7 January 2021

10.1016/S0959-8049(97)00250-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9337688%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference